Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Ceapro Inc V.CZO

Chemicals Specialty Chemicals
Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human... see more

TSXV:CZO - Post Discussion

Ceapro Inc > Derisked?
View:
Post by Alex1726 on Nov 09, 2022 8:07pm

Derisked?

Not at all , all sales comes from ONE customer. J&J so do not tell me there is no risk.
Comment by Ciao on Nov 09, 2022 9:19pm
No doubt that indirectly J&J is Ceapros largest customer, but far from being the only one: https://www.ceapro.com/cosmeceuticals/overview It was a disappointing q3 given the 25% growth in H1. Historical annual rev growth at about 10% a year appeared to be on autopilot and could be better and that's been a concern for many of us.  IMHO the CRO was hired to find paths for revenue ...more  
Comment by Ciao on Nov 10, 2022 10:47am
Keep an eye on the big picture. Are you buying the company for the base business alone, discounting that every PGX initiative will be a flop? When Gilles says the company is de-risked, he means the base business (growing at 10% annually) through it's cash flow and profits has been able to support the cost of R&D without equity raises and diluting the share price or going bankrupt if ...more  
Ceapro Inc
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities